Decreased circulating anandamide levels in preeclampsia

Area of Science:

• Reproductive biology
• Endocrinology
• Maternal-fetal medicine

Background:

• The endocannabinoid system plays a crucial role in female reproduction.
• Anandamide levels are linked to pregnancy complications like miscarriage and ectopic pregnancy.
• Anandamide is also involved in blood pressure regulation.

Purpose of the Study:

• To investigate circulating anandamide levels in women with preeclampsia for the first time.
• To compare anandamide concentrations between preeclamptic patients and healthy pregnant women.

Main Methods:

• A case-control study involving 43 preeclamptic patients and 71 healthy pregnant women.
• Serum anandamide levels measured using high-performance liquid chromatography-mass spectrometry.
• Serum levels of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF) measured by electrochemiluminescence immunoassay.

Main Results:

• Serum anandamide levels were significantly lower in preeclamptic patients (0.75 ng/ml) compared to healthy pregnant women (1.30 ng/ml).
• Preeclamptic patients exhibited significantly higher sFlt-1 and lower PlGF levels.
• No correlation was found between anandamide and sFlt-1 or PlGF levels in either group.

Conclusions:

• Serum anandamide concentrations are decreased in women with preeclampsia.
• The observed decrease in anandamide in preeclampsia warrants further investigation into its causal role and consequences.